Curatis Holding AG (SWX:CURN)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
18.65
+0.55 (3.04%)
At close: Feb 27, 2026
56.72%
Market Cap 96.12M
Revenue n/a
Net Income n/a
Shares Out 5.15M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,569
Average Volume 3,410
Open 18.95
Previous Close 18.10
Day's Range 18.20 - 18.95
52-Week Range 9.14 - 19.90
Beta n/a
RSI 63.98
Earnings Date n/a

About Curatis Holding AG

Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of fentanyl, breakthrough pain, antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson’s disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ antibioticum, gentamycin collage... [Read more]

Sector Healthcare
CEO Roland Rutschmann
Employees 20
Stock Exchange SIX Swiss Exchange
Ticker Symbol CURN
Full Company Profile

News

There is no news available yet.